Church-based Health Intervention for Cardiovascular Disease
(CHERISH Trial)
Trial Summary
What is the purpose of this trial?
Cardiovascular disease (CVD) is the leading cause of death in the US general population. Although CVD mortality rates declined for both Black and White populations during the past two decades, they are still higher in Black adults than White adults. There are also persistent disparities in CVD risk factors with higher prevalence of obesity, hypertension, and diabetes in Black compared to White populations. In addition, CVD and risk factors are more prevalent in the residents of Louisiana compared to the US general population. The Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health (CHERISH) study will use a church-based community health worker (CHW)-led multifaceted intervention to address racial inequities in CVD risk factors in predominantly Black communities in New Orleans, Louisiana. The primary aim of the CHERISH study is to compare the impact of two implementation strategies - a CHW-led multifaceted strategy and a group-based education strategy - for delivering interventions recommended by the 2019 American College of Cardiology (ACC)/American Heart Association (AHA) Guideline on the Primary Prevention of Cardiovascular Disease on implementation and clinical effectiveness outcomes in predominantly Black church community members over 18 months.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of this treatment for cardiovascular disease?
Research shows that church-based health programs can help reduce risk factors for heart disease, like high blood pressure and unhealthy weight, especially in communities with a high burden of these conditions. These programs often involve education and lifestyle changes, which have been effective in improving heart health.12345
Is the church-based health intervention for cardiovascular disease safe for humans?
How is the church-based health intervention for cardiovascular disease unique compared to other treatments?
This treatment is unique because it uses church-based programs to deliver health interventions, integrating faith and community support to improve cardiovascular health, especially in high-risk groups like African Americans and rural populations. It combines evidence-based health strategies with spiritual and community elements, which can enhance engagement and effectiveness.148910
Eligibility Criteria
The CHERISH study is for Black or African American adults aged 40 and over who are connected to participating churches in New Orleans. They must have at least four of these risk factors: smoking, obesity, low physical activity, poor diet, high cholesterol, high blood pressure, or elevated blood sugar. Those with recent severe health issues like cancer treatment or heart failure aren't eligible.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Implementation
Participants receive a CHW-led multifaceted intervention or a group-based education strategy to address CVD risk factors
Follow-up
Participants are monitored for sustainability of the intervention and maintenance of cardiovascular health metrics
Treatment Details
Interventions
- Evidence-based interventions recommended by the 2019 ACC/AHA Guideline on the Primary Prevention of CVD
Evidence-based interventions recommended by the 2019 ACC/AHA Guideline on the Primary Prevention of CVD is already approved in United States for the following indications:
- Primary prevention of cardiovascular disease
Find a Clinic Near You
Who Is Running the Clinical Trial?
Tulane University
Lead Sponsor
National Institutes of Health (NIH)
Collaborator